Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease

Human Molecular Genetics

Volumn 14, Issue 10, 2005, Pages 1245-1250

  McGovern, Dermot P B ^a,b   Hysi, Pirro ^a   Ahmad, Tariq ^b   van Heel, David A ^c   Moffatt, Miriam F ^a   Carey, Alisoun ^d   Cookson, William O C ^a   Jewell, Derek P ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d Oxagen Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOTIDE BINDING PROTEIN; PROTEIN NOD1; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; EXON; FEMALE; GENE DELETION; GENE FUNCTION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN FUNCTION; ULCERATIVE COLITIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFLAMMATORY BOWEL DISEASES; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NOD1 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, GENETIC; SEQUENCE DELETION;

BACTERIA (MICROORGANISMS);

EID: 19744366535     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddi135     Document Type: Article

References (31)

1. Rubin, G.P., Hungin, A.P., Kelly, P.J. and Ling, J. (2000) Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment. Pharmacol. Ther., 14, 1553-1559.
2. Hugot, J.P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J.P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C.A., Gassull, M. et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature, 411, 599-603.
3. Ogura, Y., Bonen, D.K., Inohara, N., Nicolae, D.L., Chen, F.F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R.H. et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature, 411, 603-606.
4. Inohara, N., Ogura, Y., Fontalba, A., Gutierrez, O., Pons, F., Crespo, J., Fukase, K., Inamura, S., Kusumoto, S., Hashimoto, M. et al. (2003) Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem., 278, 5509-5512.
5. van Heel, D.A., McGovern, D.P., Cardon, L.R., Dechairo, B.M., Lench, N.J., Carey, A.H. and Jewell, D.P. (2002) Fine mapping of the IBD1 locus did not identify Crohn disease-associated NOD2 variants: implications for complex disease genetics. Am. J. Med. Genet., 111, 253-259.
6. Ahmad, T., Armuzzi, A., Bunce, M., Mulcahy-Hawes, K., Marshall, S.E., Orchard, T.R., Crawshaw, J., Large, O., de Silva, A., Cook, J.T. et al. (2002) The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology, 122, 854-866.
7. Lesage, S., Zouali, H., Cezard, J.P., Colombel, J.F., Belaiche, J., Almer, S., Tysk, C., O'Morain, C., Gassull, M., Binder, V. et al. (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am. J. Hum. Genet., 70, 845-857.
8. McGovern, D.P., van Heel, D.A., Negoro, K., Ahmad, T. and Jewell, D.P. (2003) Further evidence of IBD5/CARD15 (NOD2) epistasis in the susceptibility to ulcerative colitis. Am. J. Hum. Genet., 73, 1465-1466.
9. Cho, J.H., Nicolae, D.L., Gold, L.H., Fields, C.T., LaBuda, M.C., Rohal, P.M., Pickles, M.R., Qin, L., Fu, Y., Mann, J.S. et al. (1998) Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc. Natl. Acad. Sci. USA, 95, 7502-7507.
10. Rioux, J.D., Silverberg, M.S., Daly, M.J., Steinhart, A.H., McLeod, R.S., Griffiths, A.M., Green, T., Brettin, T.S., Stone, V., Bull, S.B. et al. (2000) Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am. J. Hum. Genet., 66, 1863-1870.
11. Hampe, J., Schreiber, S., Shaw, S.H., Lau, K.F., Bridger, S., Macpherson, A.J., Cardon, L.R., Sakul, H., Harris, T.J., Buckler, A. et al. (1999) A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am. J. Hum. Genet., 64, 808-816.
12. Ma, Y., Ohmen, J.D., Li, Z., Bentley, L.G., McElree, C., Pressman, S., Targan, S.R., Fischel-Ghodsian, N., Rotter, J.I. and Yang, H. (1999) A genome-wide search identifies potential new susceptibility loci for Crohn's disease. Inflamm. Bowel. Dis., 5, 271-278.
13. Duerr, R.H., Barmada, M.M., Zhang, L., Pfutzer, R. and Weeks, D.E. (2000) High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. Am. J. Hum. Genet., 66, 1857-1862.
14. van Heel, D.A., Dechairo, B.M., Dawson, G., McGovern, D.P., Negoro, K., Carey, A.H., Cardon, L.R., Mackay, I., Jewell, D.P. and Lench, N.J. (2003) The IBD6 Crohn's disease locus demonstrates complex interactions with CARD 15 and IBD5 disease-associated variants. Hum. Mol. Genet., 12, 2569-2575.
15. Rioux, J.D., Daly, M.J., Silverberg, M.S., Lindblad, K., Steinhart, H., Cohen, Z., Delmonte, T., Kocher, K., Miller, K., Guschwan, S. et al. (2001) Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat. Genet., 29, 223-228.
16. Stoll, M., Corneliussen, B., Costello, C.M., Waetzig, G.H., Mellgard, B., Koch, W.A., Rosenstiel, P., Albrecht, M., Croucher, P.J., Seegert, D. et al. (2004) Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat. Genet., 36, 476-480.
17. Peltekova, V.D., Wintle, R.F., Rubin, L.A., Amos, C.I., Huang, Q., Gu, X., Newman, B., van Oene, M., Cescon, D., Greenberg, G. et al. (2004) Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat. Genet., 36, 471-475.
18. Satsangi, J., Parkes, M., Louis, E., Hashimoto, L., Kato, N., Welsh, K., Terwilliger, J.D., Lathrop, G.M., Bell, J.I. and Jewell, D.P. (1996) Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat. Genet., 14, 199-202.
19. van Heel, D.A., Fisher, S.A., Kirby, A., Daly, M.J., Rioux, J.D. and Lewis, C.M. (2004) Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum. Mol. Genet., 13, 763-770.
20. Chamaillard, M., Hashimoto, M., Horie, Y., Masumoto, J., Qiu, S., Saab, L., Ogura, Y., Kawasaki, A., Fukase, K., Kusumoto, S. et al. (2003) An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol., 4, 702-707.
21. Zouali, H., Lesage, S., Merlin, F., Cezard, J.P., Colombel, J.F., Belaiche, J., Almer, S., Tysk, C., O'Morain, C., Gassull, M. et al. (2003) CARD4/NOD1 is not involved in inflammatory bowel disease. Gut, 52, 71-74.
22. Hysi, P., Kabesch, M., Moffatt, M.F., Schedel, M., Carr, D., Zhang, Y., Boardman, B., von Mutius, E., Weiland, S., Leupold, W. et al. (2005) NOD1 variation, immunoglobulin E and asthma. Hum. Mol. Genet., 14, 935-941.
23. Girardin, S.E., Tournebize, R., Mavris, M., Page, A.L., Li, X., Stark, G.R., Bertin, J., DiStefano, P.S., Yaniv, M., Sansonetti, P.J. et al. (2001) CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep., 2, 736-742.
24. Kim, J.G., Lee, S.J. and Kagnoff, M.F. (2004) Nod1 is an essential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by toll-like receptors. Infect. Immun., 72, 1487-1495.
25. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. and Muller, W. (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell, 75, 263-274.
26. Rutgeerts, P., Hiele, M., Geboes, K., Peeters, M., Penninckx, F., Aerts, R. and Kerremans, R. (1995) Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology, 108, 1617-1621.
27. Rutgeerts, P., Goboes, K., Peeters, M., Hiele, M., Penninckx, F., Aerts, R., Kerremans, R. and Vantrappen, G. (1991) Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet, 338, 771-774.
28. Negoro, K., McGovern, D.P., Kinouchi, Y., Takahashi, S., Lench, N.J., Shimosegawa, T., Carey, A., Cardon, L.R., Jewell, D.P. and van Heel, D.A. (2003) Analysis of the IBD5 locus and potential gene - gene interactions in Crohn's disease. Gut, 52, 541-546.
29. Abecasis, G.R., Cherny, S.S., Cookson, W.O. and Cardon, L.R. (2002) Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat. Genet., 30, 97-101.
30. Abecasis, G.R. and Cookson, W.O. (2000) GOLD-graphical overview of linkage disequilibrium. Bioinformatics, 16, 182-183.
31. Sham, P.C. and Curtis, D. (1995) An extended transmission/ disequilibrium test (TDT) for multi-allele marker loci. Ann. Hum. Genet., 59, 323-336.